HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Market Closed 04-10 16:09:20

38.760

+0.180

+0.47%

High39.360	Low38.160	Vol7.82M
Open39.360	D1 Closing38.580	Amplitude3.11%
Mkt Cap234.69B	Tradable Cap234.69B	Total Shares6.06B
T/O302.35M	T/O Rate0.13%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":38.76,"timestamp":1775808560007,"preClose":38.58,"halted":0,"volume":7824145,"delay":0,"changeRate":0.004665629860031097,"floatShares":6055000000,"shares":6055000000,"eps":1.0659017857142858,"marketStatus":"Market Closed","change":0.18,"latestTime":"04-10 16:09:20","open":39.36,"high":39.36,"low":38.16,"amount":302351571,"amplitude":0.031104,"askPrice":38.76,"askSize":38000,"bidPrice":38.7,"bidSize":46000,"shortable":3,"etf":0,"ttmEps":1.0659017857142858,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":7,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":38.58,"dividendRate":0.011317,"openAndCloseTimeList":[[1775784600000,1775793600000],[1775797200000,1775808000000]],"volumeRatio":0.43534871458980073,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692/tweets","defaultTab":"tweets","newsList":[{"id":"2625629423","title":"Hansoh Pharmaceutical R&D Spend Should Boost Earnings Sustainability -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2625629423","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625629423?lang=en_us&edition=fundamental","pubTime":"2026-04-06 10:18","pubTimestamp":1775441880,"startTime":"0","endTime":"0","summary":"0218 GMT - Hansoh Pharmaceutical is expected to increase R&D spending in 2026, which should continue to fuel business-development income on a sustained basis, CMB International analysts Jill Wu and Andy Wang say in a note. The brokerage forecasts the company's 2026 revenue to rise 11.1% to 16.81 billion yuan, with net profit increasing 3.6% to 5.77 billion yuan. CMB International raises its target price to HK$46.41 from HK$45.26 while maintaining a buy rating. The stock last traded at HK$39.36. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624618973","title":"Assessing Hansoh Pharmaceutical Group (SEHK:3692) Valuation After Earnings Growth And New XINYUE Indication Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2624618973","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624618973?lang=en_us&edition=fundamental","pubTime":"2026-04-04 20:21","pubTimestamp":1775305316,"startTime":"0","endTime":"0","summary":"What the latest earnings and drug news mean for Hansoh Pharmaceutical Group\nThe latest move in Hansoh Pharmaceutical Group (SEHK:3692) is being shaped by two fresh developments: full year 2025 earnings and new regulatory progress for its autoimmune drug XINYUE in China.\nFor the year ended 31 December 2025, Hansoh Pharmaceutical Group reported sales of CN¥15,028.32 million, compared with CN¥12,260.81 million a year earlier, and net income of CN¥5,555.46 million versus CN¥4,371.83...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/assessing-hansoh-pharmaceutical-group-sehk3692-valuation-aft-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/assessing-hansoh-pharmaceutical-group-sehk3692-valuation-aft-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03692","DCF","BK1583","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165753993","title":"CMB International Reaffirms \"Buy\" Rating for HANSOH PHARMA, Raises Target Price to HK$46.41","url":"https://stock-news.laohu8.com/highlight/detail?id=1165753993","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165753993?lang=en_us&edition=fundamental","pubTime":"2026-04-04 19:56","pubTimestamp":1775303794,"startTime":"0","endTime":"0","summary":"CMB International has released a research report maintaining a \"Buy\" rating for HANSOH PHARMA (03692). The report forecasts revenue growth of 11.1% and 5.6% year-on-year for 2026 and 2027,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","03692","BK1191","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659555","title":"Hansoh Pharma says China approves Xinyue for generalized myasthenia gravis indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659555","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624659555?lang=en_us&edition=fundamental","pubTime":"2026-04-03 17:34","pubTimestamp":1775208849,"startTime":"0","endTime":"0","summary":"Hansoh Pharma won China NMPA marketing clearance for XINYUE  to treat adult antibody-positive generalized myasthenia gravis in combination with conventional therapies.Approval marks XINYUE’s third China indication, following prior clearances in neuromyelitis optica spectrum disorder and IgG4-related disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL5gDnrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155304509","title":"Haitong International Maintains \"Outperform\" Rating on HANSOH PHARMA with HK$45.94 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1155304509","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155304509?lang=en_us&edition=fundamental","pubTime":"2026-04-03 15:37","pubTimestamp":1775201823,"startTime":"0","endTime":"0","summary":"Haitong International has released a research report raising its revenue forecasts for HANSOH PHARMA (03692) for FY26 and FY27 to RMB 170 billion and RMB 190 billion, respectively, up from previous...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","EWH","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624315066","title":"Hansoh Pharmaceutical's Drug Launches Strengthen Long-Term Outlook -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2624315066","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624315066?lang=en_us&edition=fundamental","pubTime":"2026-04-03 10:25","pubTimestamp":1775183100,"startTime":"0","endTime":"0","summary":"0225 GMT - Hansoh Pharmaceutical Group's innovative drug launches strengthen its long-term outlook, UOB Kay Hian analysts say in a research report as they maintain the stock's buy rating. The Chinese pharmaceutical company's strong 2025 results was mainly driven by a surge in innovative product sales and collaboration revenue, the analysts note. Management expects innovative drugs will continue to drive resilient revenue growth with double-digit expansion for drug sales and business development income in 2026. However, the brokerage cuts the stock's target price to HK$45.00 from HK$50.00 to factor in recent weak market sentiment. Shares last closed at HK$39.36. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158463945","title":"Hansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1158463945","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158463945?lang=en_us&edition=fundamental","pubTime":"2026-04-02 17:06","pubTimestamp":1775120773,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624956215","title":"Hansoh Pharmaceutical Group  Stock Rises 5.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2624956215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624956215?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:31","pubTimestamp":1775032260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rallied 5.5% to 37.42 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 2.0% to 25294.03.This was the stock's fourth consecutive day of gains.Hansoh Pharmaceutical Group Co. Ltd. closed 15% below its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 25.9 million shares, compared to the 50-day average of 8.4 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192541176","title":"CLSA Maintains \"Outperform\" Rating on Hansoh Pharma, Trims Target Price to HK$40","url":"https://stock-news.laohu8.com/highlight/detail?id=1192541176","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192541176?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:40","pubTimestamp":1774946453,"startTime":"0","endTime":"0","summary":"CLSA has released a research report indicating that Hansoh Pharma (03692) delivered robust performance in the second half of 2025, surpassing market expectations. Following a change in valuation...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","03692","BK1589","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623563306","title":"BUZZ-Hansoh jumps most in 19 months on annual profit beat, Citi lifts target price","url":"https://stock-news.laohu8.com/highlight/detail?id=2623563306","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623563306?lang=en_us&edition=fundamental","pubTime":"2026-03-31 15:12","pubTimestamp":1774941167,"startTime":"0","endTime":"0","summary":"BUZZ-Hansoh jumps most in 19 months on annual profit beat, Citi lifts target price ** Shares of China's Hansoh Pharmaceutical Group 3692.HK jump 8.6% to HK$35.94, on track for biggest one-day pct gain since August 2024 ** Stock hits the highest point since February 24 in the third straight session of gains; top pct gainer in the Hang Seng Biotech Index .HSBIO, which slips 0.2% ** Hansoh, a Roche ROG.S partner, reports a 27% y/y rise in 2025 annual profit, beating market expectations and boosted by income from innovative medicines and business development deals** Citi maintains \"buy\" rating on Hansoh and lifts target price to HK$49 from HK$45 as it raises FY26/27E revenue forecasts by 8%/9% to reflect latest sales trend and business development collaboration revenue** YTD, stock down 1.4%, benchmark Hang Seng Index .HSI down 3.7%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL1N40J094:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","LU1244550494.USD","LU1201861249.SGD","BK1583","LU1244550577.SGD","LU2125154935.USD","LU0310800965.SGD","LU1267930227.SGD","LU2417539215.USD","LU0314106906.USD","LU1791807156.HKD","BK4504","LU0170899867.USD","LU1244550221.USD","LU2236285917.USD","IE00BSNM7G36.USD","BK4207","BK4559","LU2456880835.USD","LU0162691827.USD","LU1366192091.USD","LU2125154778.USD","BK4585","LU1668664300.SGD","BK4588","LU0320765646.SGD","LU1506573853.SGD","LU0130517989.USD","LU0072461881.USD","LU0477156953.USD","LU0648001328.SGD","BK4534","BK4566","LU2462157665.USD","BK1191","LU0130102774.USD","BK1589","LU0980610538.SGD","LU2360032135.SGD","LU0106831901.USD","LU0098860793.USD","LU1162221912.USD","LU0128525689.USD","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150411616","title":"Stock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1150411616","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150411616?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:52","pubTimestamp":1774925564,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.The significant price movement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173691271","title":"HANSOH PHARMA Shares Surge Over 6% in Morning Trading Following Strong Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1173691271","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173691271?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:51","pubTimestamp":1774925467,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million. The company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623340500","title":"Hansoh Pharmaceutical Group (SEHK:3692) Net Margin Strength Backs Bullish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2623340500","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623340500?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:10","pubTimestamp":1774876230,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group (SEHK:3692) just posted its FY 2025 first half results with revenue of C¥7.4b and basic EPS of C¥0.53, against a trailing twelve month backdrop of C¥15.0b in revenue and C¥0.93 in EPS off C¥5.6b in net income, as well as earnings growth of 27.1% over the past year. The company has seen revenue move from C¥6.5b and EPS of C¥0.46 in 1H FY 2024 to C¥5.8b and EPS of C¥0.28 in 2H FY 2024, and now to C¥7.4b and EPS of C¥0.53 in 1H FY 2025. This sets up a story where rich...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-net-margin-strength-bac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-net-margin-strength-bac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4112","BK1191","BLSG","BK1583","BK1589","BLSX","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397779","title":"Hansoh Pharmaceutical Group  Stock Climbs 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397779","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623397779?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:33","pubTimestamp":1774859580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rose 1.6% to 33.08 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 24750.79.This was the stock's second consecutive day of gains.Hansoh Pharmaceutical Group Co. Ltd. closed 25% short of its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 10.1 million shares, compared to the 50-day average of 8.1 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623562893","title":"Hansoh Pharmaceutical proposes final dividend of HKD 0.2 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2623562893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623562893?lang=en_us&edition=fundamental","pubTime":"2026-03-29 20:11","pubTimestamp":1774786285,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical proposed a final dividend of HKD 0.2 per share for year ended Dec. 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nNDL2ZwCqL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","03692","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623356495","title":"China's Hansoh Pharmaceutical Group beats net profit expectations in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2623356495","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623356495?lang=en_us&edition=fundamental","pubTime":"2026-03-29 20:08","pubTimestamp":1774786084,"startTime":"0","endTime":"0","summary":"China's Hansoh Pharmaceutical Group beats net profit expectations in 2025SHANGHAI, March 29  - China's Hansoh Pharmaceutical Group 3692.HK, a Roche partner, reported a 27% rise in annual profit on Sunday, beating market expectations and boosted by income from innovative medicines and business development deals.The specialist in oncology, anti-infective, central nervous system disease, metabolic disease and autoimmune disease drugs has expanded licensing deals and developed innovative medicines amid Beijing's centralised bulk buying programmes, which have squeezed generic drug revenues.Hansoh said net profit for the 2025 fiscal year that ended December 31 came in at 5.56 billion yuan , well above a consensus forecast of 4.97 billion yuan in estimates compiled by LSEG. Revenue for the year jumped 22.6% to 15.03 billion yuan, the company said.In October, Hansoh signed a licence agreement worth up to $1.45 billion with Roche ROG.S for an investigational treatment of colorectal cancer and o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nL6N3ZY0K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2362540622.SGD","BK4588","LU0053666078.USD","LU1917777945.USD","LU1974910355.USD","LU0289739699.SGD","BK4139","LU0058720904.USD","LU0823416689.USD","BK4585","LU2362541273.HKD","LU2237438978.USD","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","LU0882574055.USD","LU2106854487.HKD","BK1583","LU0320765992.SGD","LU0114720955.EUR","03692","LU2362541513.USD","REGN","LU0109394709.USD","LU0889565916.HKD","LU2468319806.SGD","LU2023250504.SGD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623356498","title":"Hansoh Pharma FY25 profit climbs 27.1% to RMB 5.6 billion; revenue rises 22.6% to RMB 15 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2623356498","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623356498?lang=en_us&edition=fundamental","pubTime":"2026-03-29 20:07","pubTimestamp":1774786047,"startTime":"0","endTime":"0","summary":"Hansoh Pharma FY25 profit for the year climbed 27.1% to RMB 5.6 billion.Basic earnings per share increased 26.4% to RMB 0.93.Innovative medicines and collaborative products revenue jumped 30.4% to RMB 12.4 billion, lifting mix to 82.2% of revenue.Board recommended final dividend of HK$0.20 per share; full-year dividend totaled HK$0.43 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on March 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nNDL37Ddny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136633293","title":"HANSOH PHARMA Reports Annual Profit Attributable to Shareholders of RMB 55.55 Billion, Up 27.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136633293","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136633293?lang=en_us&edition=fundamental","pubTime":"2026-03-29 19:44","pubTimestamp":1774784660,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) announced its annual results for the period ended December 31, 2025. The group recorded revenue of RMB 150.28 billion, representing a year-on-year increase of 22.57%. Profit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187198661","title":"Hansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Payable on 24 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1187198661","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187198661?lang=en_us&edition=fundamental","pubTime":"2026-03-29 19:44","pubTimestamp":1774784643,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623593356","title":"Hansoh Pharmaceutical  2025 Profit Attributable to Owners of Parent at 5.56 Bln Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2623593356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623593356?lang=en_us&edition=fundamental","pubTime":"2026-03-29 19:37","pubTimestamp":1774784244,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nL4N40H045:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","03692","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":0.1522},{"period":"3month","weight":-0.0683},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.7856},{"period":"ytd","weight":0.0743}],"compareEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":-0.0002},{"period":"3month","weight":-0.0129},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.252},{"period":"ytd","weight":0.0103}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.040644},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}